Novartis AG (NVSEF)
94.74
-2.26
(-2.33%)
USD |
OTCM |
May 03, 16:00
Novartis Price: 94.74 for May 3, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 03, 2024 | 94.74 | 94.74 | 94.74 | 94.74 | 221.00 |
| May 02, 2024 | 97.00 | 97.00 | 97.00 | 97.00 | 0.000 |
| May 01, 2024 | 97.00 | 97.00 | 97.00 | 97.00 | 0.000 |
| Apr 30, 2024 | 97.00 | 97.00 | 97.00 | 97.00 | 213.00 |
| Apr 29, 2024 | 96.00 | 96.00 | 96.00 | 96.00 | 0.000 |
| Apr 26, 2024 | 96.00 | 96.00 | 96.00 | 96.00 | 0.000 |
| Apr 25, 2024 | 96.00 | 96.00 | 96.00 | 96.00 | 0.000 |
| Apr 24, 2024 | 96.00 | 96.00 | 96.00 | 96.00 | 0.000 |
| Apr 23, 2024 | 96.72 | 96.74 | 95.36 | 96.00 | 51948.00 |
| Apr 22, 2024 | 95.27 | 95.27 | 95.11 | 95.11 | 492.00 |
| Apr 19, 2024 | 90.24 | 90.24 | 90.24 | 90.24 | 0.000 |
| Apr 18, 2024 | 90.24 | 90.24 | 90.24 | 90.24 | 10985.00 |
| Apr 17, 2024 | 93.64 | 93.64 | 93.64 | 93.64 | 0.000 |
| Apr 16, 2024 | 93.64 | 93.64 | 93.64 | 93.64 | 0.000 |
| Apr 15, 2024 | 93.64 | 93.64 | 93.64 | 93.64 | 0.000 |
| Apr 12, 2024 | 93.64 | 93.64 | 93.64 | 93.64 | 0.000 |
| Apr 11, 2024 | 93.80 | 94.25 | 93.64 | 93.64 | 82320.00 |
| Apr 10, 2024 | 94.10 | 94.10 | 94.10 | 94.10 | 504.00 |
| Apr 09, 2024 | 95.70 | 95.70 | 95.70 | 95.70 | 1698.00 |
| Apr 08, 2024 | 94.91 | 94.91 | 94.91 | 94.91 | 0.000 |
| Apr 05, 2024 | 94.91 | 94.91 | 94.91 | 94.91 | 0.000 |
| Apr 04, 2024 | 94.82 | 97.11 | 94.82 | 94.91 | 5408.00 |
| Apr 03, 2024 | 92.28 | 92.44 | 92.28 | 92.44 | 400.00 |
| Apr 02, 2024 | 95.00 | 95.00 | 95.00 | 95.00 | 6373.00 |
| Apr 01, 2024 | 96.51 | 96.51 | 96.51 | 96.51 | 0.000 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
57.21
Minimum
Mar 18 2020
109.00
Maximum
Jan 23 2024
76.58
Average
73.75
Median
May 27 2021
Price Benchmarks
| Sandoz Group AG | 34.21 |
| Roche Holding AG | 29.83 |
| Bristol-Myers Squibb Co | 43.99 |
| ADC Therapeutics SA | 4.90 |
Price Related Metrics
| PE Ratio | 12.92 |
| PS Ratio | 3.938 |
| PEG Ratio | 0.103 |
| Price to Book Value | 4.872 |
| Price to Free Cash Flow | 19.19 |
| Earnings Yield | 7.74% |
| Market Cap | 193.31B |
| PEGY Ratio | 0.0998 |
| Operating PE Ratio | 18.48 |
| Normalized PE Ratio | 21.43 |